Psychedelics are a group of psychoactive drugs that can induce hallucinations and feelings of euphoria. Although some research suggests they can treat certain mental health conditions, they can cause dependence and be dangerous if misused.
Some cultures use psychedelics for religious and spiritual practices. People also use psychedelics for recreational purposes, although many psychedelic substances are controlled and illegal in the United States.
Emerging evidence suggests that certain psychedelics may have medicinal benefits for a range of health conditions, particularly common mental health conditions such as anxiety and depression.
This article discusses the characteristics, potential medicinal benefits, and risks of psychedelics.
Psychedelics are also known as hallucinogens because taking them can result in hallucinations. Hallucinations are sensory experiences that cause a person to see, hear, smell, taste, or feel things that are not really there. Someone who takes psychedelics may experience changes in their awareness of their thoughts and surroundings.
Some psychedelics come from plants or mushrooms (often referred to as magic mushrooms), while others are synthetic and manufactured by humans.
According to the National Institute on Drug Abuse (NIDA), there are two main types of psychedelics: classic hallucinogens and dissociative drugs.
Classic hallucinogens include substances such as:
LSD is a potent mind-altering chemical that is clear or white in color and has no smell. It is made from lysergic acid, which is found in a fungus that grows on grains.
Psilocybin is the main active ingredient in magic mushrooms, which include a wide range of mushrooms found in tropical and subtropical regions of South America, Mexico, and the U.S.
Peyote is a small cactus native to Mexico and southern regions of the U.S. It can also be synthetic.
It is used in some Native American religious ceremonies, but the Drug Enforcement Administration (DEA) restricts it as a Schedule I substance. It contains mescaline, which can cause hallucinations, altered body image, and euphoria.
DMT is a powerful chemical present in certain plant groups, including Phalaris, Delosperma, Acacia, Mimosa, and in the leaves of citrus plants. People can make a tea called ayahuasca, which is also known as hoasca, aya, or yag, from the natural plant version.
There is also a synthetic version of DMT, which is a white powder that people can smoke.
251-NBOMe is a synthetic substance originally developed by neuroscience researchers. It has similar qualities to LSD and MDMA. MDMA stands for 3,4-Methylenedioxymethamphetamine, and is a recreational psychoactive drug. However, 251-NBOMe is more powerful than LSD and MDMA.
Dissociative drugs include substances such as:
Surgeons used PCP in the 1950s as a general anesthetic, but manufacturers stopped producing it due to its serious side effects, which included postoperative delirium and hallucinations. At high doses, PCP can cause seizures, severe muscle contractions, violent or aggressive behavior, and symptoms of psychosis.
At lower doses, PCP can cause feelings of detachment from a persons surroundings and self, slurred speech, and loss of coordination. It is also a strong pain reliever.
The effects of PCP can develop within 25 minutes after smoking, and 3060 minutes after swallowing. Some people experience these effects for 48 hours.
It is an illegal, schedule II controlled drug. Its street names include:
A person can consume PCP by smoking, snorting, or swallowing the drug. It comes in powder, crystal, tablet, capsules, and liquid forms, with powder and liquid PCP being the most commonly sold forms.
Doctors and veterinarians use ketamine as an anesthetic for humans and animals undergoing surgery.
According to the DEA, most of the illegally-distributed ketamine is stolen from veterinary surgeries. It is often sold at parties, nightclubs, and raves. It is manufactured commercially as a liquid or powder. Liquid ketamine can be mixed into drinks. Powder ketamine can be smoked and snorted.
A person who takes ketamine may experience distortions to sights and sounds, feelings of dissociation, and a sense of calm. It also relieves pain.
It is also used to facilitate sexual assault and is also known as a date rape drug.
Its effects can last for 3060 minutes.
Its street names include:
DXM is found in a wide range of over-the-counter cold and cough medicines, such as syrups, tablets, and gel capsules. It is a cough suppressor that does not tend to cause side effects.
It is not an illegal or controlled substance because it is used to treat health conditions. When taken as a treatment for a cough, a typical dose for adults is between 1530 milligrams (mg), three to four times a day.
However, some people misuse DXM to achieve the feelings of euphoria it creates when taken in doses of 2501,500 mg much higher than the therapeutic range.
When a person takes DXM at these higher doses, it can have hallucinatory effects. It can also cause confusion, inappropriate laughter, agitation, paranoia, and a feeling of floating.
Salvia is a plant native to Mexico.
Its common street names are Maria Pastora, sally-D, and salvia.
People can smoke, chew, or vaporize Salvia, and its effects can come on quickly.
Some effects can include seeing bright lights and colors, shapes, and visual distortions of bodies or objects. It can also cause feelings of panic, fear, and paranoia, as well as hallucinations and uncontrollable laughter.
According to the DEA, Salvia is not a controlled substance under the Controlled Substances Act, although some U.S. states do control it.
Researchers have found a range of possible medical benefits of psychedelics, including:
An animal study published in Neuropsychopharmacologyin 2022 suggests that repeat doses of LSD over time can help to reduce stress-related anxiety and depression symptoms.
In terms of LSDs effects on humans, a 2018 study in Psychopharmacology found that people taking LSD in conjunction with having psychotherapy sessions reported increased feelings of happiness, trust, and empathy, resulting in positive social effects and altruism.
Furthermore, in 2019, the U.S. Food & Drug Administration (FDA) approved a drug closely related to ketamine, called esketamine, for treating severe depression in people for whom other treatments dont work.
Psilocybin may also be helpful in the treatment of depression and anxiety when these mental health conditions are specifically linked to life threatening diseases, according to a 2020 systematic review and meta-analyses of clinical trials in Biomedicines.
Authors of a 2017 study into the therapeutic effects of psilocybin stated that more research is needed to confirm whether this particular psychedelic can benefit OCD after a small, 2009 study stated it decreased OCD symptoms in all of its study participants.
The 2017 study stated that participants experienced reductions in their symptoms regardless of the dose they took and questioned whether the results were influenced by a placebo effect.
In a 2017 qualitative study in Harm Reduction Journal, researchers explored how alternative treatments, including psychedelics, could help people with migraine and cluster headaches. People using these substances for this purpose reported that psilocybin, LSD, and related psychedelics worked to prevent and treat cluster headaches and migraine.
According to a 2018 review, between the 1950s and 1970s, researchers carried out early phase studies investigating the effectiveness of classic psychedelics, but then discontinued their work. However, the evidence available from that time suggests that classic hallucinogens can be effective therapies, especially in the case of treating alcoholism with LSD.
Additionally, the authors of a 2020 systematic review found evidence to further support this therapeutic use.
This research presents encouraging evidence for the use of psychedelics in the treatment of a range of health conditions. However, researchers need to carry out more, and larger, well-designed clinical trials to help medical regulatory agencies decide whether to authorize psychedelics as medical treatments.
People who use psychedelics may experience one or several of a range of side effects, which range from moderate to severe. Along with the altered perception of reality that comes with hallucinations, which may be frightening to experience, short-term side effects of psychedelics can include paranoia and psychosis.
Psychedelic-induced psychosis can also persist in some people. These individuals can experience ongoing mental health issues, such as paranoia, altered mood, and visual disturbances.
Other people may experience a type of flashback known as Hallucinogen Persisting Perception Disorder (HPPD). The flashbacks can happen between a few days to over a year after the person took the psychedelics. People have sometimes mistaken the associated symptoms for a stroke or brain tumor.
In the most serious of cases, the long-term effects of using dissociative drugs, in particular, may include suicidal thoughts.
Psychedelics come in two main categories: classic hallucinogens and dissociative drugs. Emerging research suggests a range of potential therapeutic uses for psychedelics, from treating anxiety and depression to reducing the symptoms of OCD.
However, scientists need to carry out more clinical studies to investigate how effective psychedelics are for health conditions and the safety and long-term effects of psychedelics.
Additionally, many psychedelics are illegal and can cause dependence.
Originally posted here:
Psychedelics: Risks, benefits, and more - Medical News Today
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- 5 Things to Know About Colorados Psychedelics Ballot Initiative - Kaiser Health News - October 15th, 2022 [October 15th, 2022]